138 related articles for article (PubMed ID: 33300308)
1. Modelling and Phenotypic Screening of NAP-6 and 10-Cl-BBQ, AhR Ligands Displaying Selective Breast Cancer Cytotoxicity in Vitro.
Baker JR; Pollard BL; Lin AJS; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2021 May; 16(9):1499-1512. PubMed ID: 33300308
[TBL] [Abstract][Full Text] [Related]
2. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease.
Punj S; Kopparapu P; Jang HS; Phillips JL; Pennington J; Rohlman D; O'Donnell E; Iversen PL; Kolluri SK; Kerkvliet NI
PLoS One; 2014; 9(2):e88726. PubMed ID: 24586378
[TBL] [Abstract][Full Text] [Related]
4. A novel naphthalimide that selectively targets breast cancer via the arylhydrocarbon receptor pathway.
Gilbert J; De Iuliis GN; McCluskey A; Sakoff JA
Sci Rep; 2020 Aug; 10(1):13978. PubMed ID: 32814815
[TBL] [Abstract][Full Text] [Related]
5. Amino Alcohol Acrylonitriles as Activators of the Aryl Hydrocarbon Receptor Pathway: An Unexpected MTT Phenotypic Screening Outcome.
Baker JR; Russell CC; Gilbert J; Sakoff JA; McCluskey A
ChemMedChem; 2020 Mar; 15(6):490-505. PubMed ID: 32012442
[TBL] [Abstract][Full Text] [Related]
6. (
Gilbert J; De Iuliis GN; Tarleton M; McCluskey A; Sakoff JA
Mol Pharmacol; 2018 Feb; 93(2):168-177. PubMed ID: 29269419
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth.
Elson DJ; Nguyen BD; Korjeff NA; Wilferd SF; Puig-Sanvicens V; Sang Jang H; Bernales S; Chakravarty S; Belmar S; Ureta G; Finlay D; Plaisier CL; Kolluri SK
Biochem Pharmacol; 2023 Sep; 215():115706. PubMed ID: 37506922
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
Brinkman AM; Wu J; Ersland K; Xu W
BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
[TBL] [Abstract][Full Text] [Related]
9. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
10. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
[TBL] [Abstract][Full Text] [Related]
11. Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells.
Hanieh H; Mohafez O; Hairul-Islam VI; Alzahrani A; Bani Ismail M; Thirugnanasambantham K
PLoS One; 2016; 11(12):e0167650. PubMed ID: 27907195
[TBL] [Abstract][Full Text] [Related]
12. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
Liang Y; Zhou Y; Deng S; Chen T
ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors.
Donthiboina K; Anchi P; Gurram S; Sai Mani G; Lakshmi Uppu J; Godugu C; Shankaraiah N; Kamal A
Bioorg Chem; 2020 Oct; 103():104191. PubMed ID: 32891862
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-aryl-8-hydroxy (or methoxy)-isoquinolin-1(2H)-ones as novel EGFR inhibitor by scaffold hopping.
Kang BR; Shan AL; Li YP; Xu J; Lu SM; Zhang SQ
Bioorg Med Chem; 2013 Nov; 21(22):6956-64. PubMed ID: 24094432
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anticancer/antiestrogenic activities of novel indole-benzimidazoles.
Karadayi FZ; Yaman M; Kisla MM; Keskus AG; Konu O; Ates-Alagoz Z
Bioorg Chem; 2020 Jul; 100():103929. PubMed ID: 32464404
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers.
Jaiswal AS; Hirsch-Weil D; Proulx ER; Hong S; Narayan S
Bioorg Med Chem Lett; 2014 Oct; 24(20):4850-3. PubMed ID: 25240616
[TBL] [Abstract][Full Text] [Related]
17. Effective synthesis of benzimidazoles-imidazo[1,2-a]pyrazine conjugates: A comparative study of mono-and bis-benzimidazoles for antitumor activity.
Singh I; Luxami V; Paul K
Eur J Med Chem; 2019 Oct; 180():546-561. PubMed ID: 31344614
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Glyceollins as Novel Aryl Hydrocarbon Receptor Ligands and Their Role in Cell Migration.
Pham TH; Lecomte S; Le Guevel R; Lardenois A; Evrard B; Chalmel F; Ferriere F; Balaguer P; Efstathiou T; Pakdel F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085612
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor induced intratumoral aromatase in breast cancer.
Saito R; Miki Y; Hata S; Ishida T; Suzuki T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Feb; 161(3):399-407. PubMed ID: 27900579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
